MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programs MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programs Post Contentmxct, dtilRead More You might also be interested in reading Boring market, keep stacking yall. February 12, 2025 In Mainstream ← Previous post Next post →